BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 31047877)

  • 1. BCL10 in cell survival after DNA damage.
    Luo Y; Wu J; Zou J; Cao Y; He Y; Ling H; Zeng T
    Clin Chim Acta; 2019 Aug; 495():301-308. PubMed ID: 31047877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response.
    Zhao H; Zhu M; Dou G; Zhao H; Zhu B; Li J; Liao J; Xu X
    Cell Cycle; 2014; 13(11):1777-87. PubMed ID: 24732096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL10 is recruited to sites of DNA damage to facilitate DNA double-strand break repair.
    Ismail IH; Dronyk A; Hu X; Hendzel MJ; Shaw AR
    Cell Cycle; 2016; 15(1):84-94. PubMed ID: 26771713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.
    Staal J; Driege Y; Haegman M; Borghi A; Hulpiau P; Lievens L; Gul IS; Sundararaman S; Gonçalves A; Dhondt I; Pinzón JH; Braeckman BP; Technau U; Saeys Y; van Roy F; Beyaert R
    Front Immunol; 2018; 9():1136. PubMed ID: 29881386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival.
    Zhang S; Pan D; Jia XM; Lin X; Zhao X
    Protein Cell; 2017 Nov; 8(11):856-860. PubMed ID: 28717989
    [No Abstract]   [Full Text] [Related]  

  • 7. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
    David L; Li Y; Ma J; Garner E; Zhang X; Wu H
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL10 - Bridging CARDs to Immune Activation.
    Gehring T; Seeholzer T; Krappmann D
    Front Immunol; 2018; 9():1539. PubMed ID: 30022982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.
    Seeholzer T; Kurz S; Schlauderer F; Woods S; Gehring T; Widmann S; Lammens K; Krappmann D
    Front Immunol; 2018; 9():2695. PubMed ID: 30515170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A
    De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
    Front Immunol; 2018; 9():2366. PubMed ID: 30429846
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular architecture and regulation of BCL10-MALT1 filaments.
    Schlauderer F; Seeholzer T; Desfosses A; Gehring T; Strauss M; Hopfner KP; Gutsche I; Krappmann D; Lammens K
    Nat Commun; 2018 Oct; 9(1):4041. PubMed ID: 30279415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
    Jost PJ; Weiss S; Ferch U; Gross O; Mak TW; Peschel C; Ruland J
    J Immunol; 2007 Jan; 178(2):953-60. PubMed ID: 17202357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IκB kinase β in regulating the remodeling of the CARMA1-Bcl10-MALT1 complex.
    Karim ZA; Hensch NR; Qasim H; Alshbool FZ; Khasawneh FT
    Biochem Biophys Res Commun; 2018 Jun; 500(2):268-274. PubMed ID: 29649481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
    Kingeter LM; Schaefer BC
    J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
    Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
    Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
    Juilland M; Thome M
    Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
    Lu HY; Bauman BM; Arjunaraja S; Dorjbal B; Milner JD; Snow AL; Turvey SE
    Front Immunol; 2018; 9():2078. PubMed ID: 30283440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK3β modulates NF-κB activation and RelB degradation through site-specific phosphorylation of BCL10.
    Abd-Ellah A; Voogdt C; Krappmann D; Möller P; Marienfeld RB
    Sci Rep; 2018 Jan; 8(1):1352. PubMed ID: 29358699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.
    Yang C; Zang W; Tang Z; Ji Y; Xu R; Yang Y; Luo A; Hu B; Zhang Z; Liu Z; Zheng X
    Cancer Res; 2018 Feb; 78(4):1069-1082. PubMed ID: 29233925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases.
    Li C; Inagaki H; Kuo TT; Hu S; Okabe M; Eimoto T
    Am J Surg Pathol; 2003 Aug; 27(8):1061-9. PubMed ID: 12883238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.